1 Introduction to Research & Analysis Reports 1.1 Systemic Psoriasis Therapeutics Market Definition 1.2 Market Segments 1.2.1 Segment by Type 1.2.2 Segment by Application 1.3 United States Systemic Psoriasis Therapeutics Market Overview 1.4 Methodology & Sources of Information 1.4.1 Research Methodology 1.4.2 Research Process 1.4.3 Base Year 2 United States Systemic Psoriasis Therapeutics Overall Market Size 2.1 United States Systemic Psoriasis Therapeutics Market Size: 2021 VS 2027 2.2 United States Systemic Psoriasis Therapeutics Revenue, Prospects & Forecasts: 2016-2027 2.3 Key Market Trends, Opportunity, Drivers and Restraints 2.3.1 Market Opportunities & Trends 2.3.2 Market Drivers 2.3.3 Market Restraints 3 Company Landscape 3.1 Top Systemic Psoriasis Therapeutics Players in United States Market 3.2 Top United States Systemic Psoriasis Therapeutics Companies Ranked by Revenue 3.3 United States Systemic Psoriasis Therapeutics Revenue by Companies 3.4 Top 3 and Top 5 Systemic Psoriasis Therapeutics Companies in United States Market, by Revenue in 2020 3.5 Companies Systemic Psoriasis Therapeutics Product Type 3.6 Tier 1, Tier 2 and Tier 3 Systemic Psoriasis Therapeutics Players in United States Market 3.6.1 List of Tier 1 Systemic Psoriasis Therapeutics Companies in United States 3.6.2 List of Tier 2 and Tier 3 Systemic Psoriasis Therapeutics Companies in United States 4 Sights by Type 4.1 Overview 4.1.1 By Type - United States Systemic Psoriasis Therapeutics Market Size Markets, 2021 & 2027 4.1.2 Biologics 4.1.3 Small Molecules 4.2 By Type - United States Systemic Psoriasis Therapeutics Revenue & Forecasts 4.2.1 By Type - United States Systemic Psoriasis Therapeutics Revenue, 2016-2021 4.2.2 By Type - United States Systemic Psoriasis Therapeutics Revenue, 2022-2027 4.2.3 By Type - United States Systemic Psoriasis Therapeutics Revenue Market Share, 2016-2027 5 Sights by Application 5.1 Overview 5.1.1 By Application - United States Systemic Psoriasis Therapeutics Market Size, 2021 & 2027 5.1.2 Mild Psoriasis 5.1.3 Moderate Psoriasis 5.1.4 Severe Psoriasis 5.2 By Application - United States Systemic Psoriasis Therapeutics Revenue & Forecasts 5.2.1 By Application - United States Systemic Psoriasis Therapeutics Revenue, 2016-2021 5.2.2 By Application - United States Systemic Psoriasis Therapeutics Revenue, 2022-2027 5.2.3 By Application - United States Systemic Psoriasis Therapeutics Revenue Market Share, 2016-2027 6 Systemic Psoriasis Therapeutics Companies Profiles 6.1 AbbVie 6.1.1 AbbVie Company Details 6.1.2 AbbVie Business Overview 6.1.3 AbbVie Systemic Psoriasis Therapeutics Introduction 6.1.4 AbbVie Systemic Psoriasis Therapeutics Revenue in United States Market (2016-2021) 6.1.5 AbbVie Recent Developments 6.2 Johnson & Johnson 6.2.1 Johnson & Johnson Company Details 6.2.2 Johnson & Johnson Business Overview 6.2.3 Johnson & Johnson Systemic Psoriasis Therapeutics Introduction 6.2.4 Johnson & Johnson Systemic Psoriasis Therapeutics Revenue in United States Market (2016-2021) 6.2.5 Johnson & Johnson Recent Developments 6.3 Celgene 6.3.1 Celgene Company Details 6.3.2 Celgene Business Overview 6.3.3 Celgene Systemic Psoriasis Therapeutics Introduction 6.3.4 Celgene Systemic Psoriasis Therapeutics Revenue in United States Market (2016-2021) 6.3.5 Celgene Recent Developments 6.4 Amgen 6.4.1 Amgen Company Details 6.4.2 Amgen Business Overview 6.4.3 Amgen Systemic Psoriasis Therapeutics Introduction 6.4.4 Amgen Systemic Psoriasis Therapeutics Revenue in United States Market (2016-2021) 6.4.5 Amgen Recent Developments 6.5 Pfizer 6.5.1 Pfizer Company Details 6.5.2 Pfizer Business Overview 6.5.3 Pfizer Systemic Psoriasis Therapeutics Introduction 6.5.4 Pfizer Systemic Psoriasis Therapeutics Revenue in United States Market (2016-2021) 6.5.5 Pfizer Recent Developments 7 Conclusion 8 Appendix 8.1 Note 8.2 Examples of Clients 8.3 Author Details 8.4 Disclaimer

List of Tables Table 1. Systemic Psoriasis Therapeutics Market Opportunities & Trends in United States Market Table 2. Systemic Psoriasis Therapeutics Market Drivers in United States Market Table 3. Systemic Psoriasis Therapeutics Market Restraints in United States Market Table 4. Key Players of Systemic Psoriasis Therapeutics in United States Market Table 5. Top Systemic Psoriasis Therapeutics Players in United States Market, Ranking by Revenue (2019) Table 6. United States Systemic Psoriasis Therapeutics Revenue by Companies, (US$, Mn), 2016-2021 Table 7. United States Systemic Psoriasis Therapeutics Revenue Share by Companies, 2016-2021 Table 8. Companies Systemic Psoriasis Therapeutics Product Type Table 9. List of Tier 1 Systemic Psoriasis Therapeutics Companies, Revenue (US$, Mn) in 2020 and Market Share Table 10. List of Tier 2 and Tier 3 Systemic Psoriasis Therapeutics Companies, Revenue (US$, Mn) in 2020 and Market Share Table 11. By Type – United States Systemic Psoriasis Therapeutics Revenue, (US$, Mn), 2021 & 2027 Table 12. By Type - United States Systemic Psoriasis Therapeutics Revenue (US$, Mn), 2016-2021 Table 13. By Type - United States Systemic Psoriasis Therapeutics Revenue (US$, Mn), 2022-2027 Table 14. By Application – United States Systemic Psoriasis Therapeutics Revenue, (US$, Mn), 2021 VS 2027 Table 15. By Application - United States Systemic Psoriasis Therapeutics Revenue (US$, Mn), 2016-2021 Table 16. By Application - United States Systemic Psoriasis Therapeutics Revenue (US$, Mn), 2022-2027 Table 17. AbbVie Company Details Table 18. AbbVie Business Overview Table 19. AbbVie Systemic Psoriasis Therapeutics Product Table 20. AbbVie Systemic Psoriasis Therapeutics Revenue in United States Market (2016-2021) & (US$ Million) Table 21. AbbVie Recent Developments Table 22. Johnson & Johnson Company Details Table 23. Johnson & Johnson Business Overview Table 24. Johnson & Johnson Systemic Psoriasis Therapeutics Product Table 25. Johnson & Johnson Systemic Psoriasis Therapeutics Revenue in United States Market (2016-2021) & (US$ Million) Table 26. Johnson & Johnson Recent Developments Table 27. Celgene Company Details Table 28. Celgene Business Overview Table 29. Celgene Systemic Psoriasis Therapeutics Product Table 30. Celgene Systemic Psoriasis Therapeutics Revenue in United States Market (2016-2021) & (US$ Million) Table 31. Celgene Recent Developments Table 32. Amgen Company Details Table 33. Amgen Business Overview Table 34. Amgen Systemic Psoriasis Therapeutics Product Table 35. Amgen Systemic Psoriasis Therapeutics Revenue in United States Market (2016-2021) & (US$ Million) Table 36. Amgen Recent Developments Table 37. Pfizer Company Details Table 38. Pfizer Business Overview Table 39. Pfizer Systemic Psoriasis Therapeutics Product Table 40. Pfizer Systemic Psoriasis Therapeutics Revenue in United States Market (2016-2021) & (US$ Million) Table 41. Pfizer Recent Developments List of Figures Figure 1. Systemic Psoriasis Therapeutics Segment by Type Figure 2. Systemic Psoriasis Therapeutics Segment by Application Figure 3. United States Systemic Psoriasis Therapeutics Market Overview: 2020 Figure 4. United States Systemic Psoriasis Therapeutics Market Size: 2021 VS 2027 (US$, Mn) Figure 5. United States Systemic Psoriasis Therapeutics Revenue, 2016-2027 (US$, Mn) Figure 6. The Top 3 and 5 Players Market Share by Systemic Psoriasis Therapeutics Revenue in 2020 Figure 7. By Type - United States Systemic Psoriasis Therapeutics Revenue Market Share, 2016-2027 Figure 8. By Application - United States Systemic Psoriasis Therapeutics Revenue Market Share, 2016-2027 Figure 9. AbbVie Systemic Psoriasis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 10. Johnson & Johnson Systemic Psoriasis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 11. Celgene Systemic Psoriasis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 12. Amgen Systemic Psoriasis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 13. Pfizer Systemic Psoriasis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

AbbVie Johnson & Johnson Celgene Amgen Pfizer